Research On Internal Control Of W Company

Since the outbreak of the new crown epidemic,governments of various countries have adjusted their attitudes towards the research and development of drugs and vaccines,and carried out various scientific research and clinical trials.The research and development of disease detection equipment and reagents has received great attention.Biotechnology companies have provided scientific research reagents and other tool support for basic applied research and continue to benefit from them.As a biotechnology enterprise whose main business is scientific research reagents,W company has become a leader among domestic manufacturers in its long-term operation.Faced with the rapid increase in market demand,fierce competition among manufacturers for share,and industry standards are not yet perfect,how to adopt a sound and effective internal control framework system is an urgent problem that W Company needs to solve at this stage.By analyzing the case of W company,based on the principal-agent theory and risk management theory,and taking the internal control of W company as a research case,this paper systematically explained the deterioration of the company’s equity structure,the imperfect employee incentive mechanism and performance evaluation system,Lax in the cultivation of risk management awareness,insufficient customer credit screening,and insufficient analysis capabilities leading to the failure of internal control,etc.,put forward: through improving the organizational structure,optimizing the development of human resources,strengthening the training of risk identification capabilities,establishing a contracted dealer system,Strengthen the data and information security management work and other suggestions,so as to improve the internal control system of W company.Through the above optimization plan,the company helps the company establish a sound and effective internal control system,reduces various risks in its production and operation,optimizes its deficiencies in the links,and helps W company gradually achieve its business objectives and stable development.Taking W company as a research case can help other biotechnology companies and companies to be listed on optimizing their own internal control systems.On the other hand,it also provides reference materials for future scholars to study enterprise internal control issues.